|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
33 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | A Lancet Commission on sexual and reproductive health and rights: going beyond the Sustainable Development Goals |
Starrs, Ann |
2015 |
386 | 9999 |
p. 1111-1112 2 p. |
artikel |
|
| 2 | Alzheimergate? When miscommunication met sensationalism |
The Lancet, |
2015 |
386 | 9999 |
p. 1109- 1 p. |
artikel |
|
| 3 | Ana Langer: global leader in women's health |
Lane, Richard |
2015 |
386 | 9999 |
p. 1127- 1 p. |
artikel |
|
| 4 | A scorecard for tracking actions to reduce the burden of non-communicable diseases |
Roman, Ana Victoria |
2015 |
386 | 9999 |
p. 1131-1132 2 p. |
artikel |
|
| 5 | Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial |
Leder, Benjamin Z |
2015 |
386 | 9999 |
p. 1147-1155 9 p. |
artikel |
|
| 6 | Department of Error |
2015 |
386 | 9999 |
p. 1136- 1 p. |
artikel |
||
| 7 | Department of Error |
2015 |
386 | 9999 |
p. 1136- 1 p. |
artikel |
||
| 8 | Department of Error |
2015 |
386 | 9999 |
p. 1136- 1 p. |
artikel |
||
| 9 | Doxorubicin in stage II–III, intermediate-risk Wilms' tumour |
Green, Daniel M |
2015 |
386 | 9999 |
p. 1118-1119 2 p. |
artikel |
|
| 10 | How is comorbidity lived? |
Meyers, Todd |
2015 |
386 | 9999 |
p. 1128-1129 2 p. |
artikel |
|
| 11 | Interleukin-17 inhibition in psoriatic arthritis |
Helliwell, Philip |
2015 |
386 | 9999 |
p. 1114-1116 3 p. |
artikel |
|
| 12 | Love beyond death |
Weston, Gabriel |
2015 |
386 | 9999 |
p. 1126- 1 p. |
artikel |
|
| 13 | Making women count |
Horton, Richard |
2015 |
386 | 9999 |
p. 1112-1114 3 p. |
artikel |
|
| 14 | More DATA to guide sequential osteoporosis therapy |
Hofbauer, Lorenz C |
2015 |
386 | 9999 |
p. 1116-1118 3 p. |
artikel |
|
| 15 | Offline: Europe—the land of holy miracles |
Horton, Richard |
2015 |
386 | 9999 |
p. 1120- 1 p. |
artikel |
|
| 16 | Oliver Sacks |
Snyder, Alison |
2015 |
386 | 9999 |
p. 1130- 1 p. |
artikel |
|
| 17 | Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial |
Pritchard-Jones, Kathy |
2015 |
386 | 9999 |
p. 1156-1164 9 p. |
artikel |
|
| 18 | Oseltamivir for influenza |
Jones, Mark |
2015 |
386 | 9999 |
p. 1133-1134 2 p. |
artikel |
|
| 19 | Oseltamivir for influenza |
Kubo, Kenji |
2015 |
386 | 9999 |
p. 1135- 1 p. |
artikel |
|
| 20 | Oseltamivir for influenza |
Radecki, Ryan P |
2015 |
386 | 9999 |
p. 1134- 1 p. |
artikel |
|
| 21 | Oseltamivir for influenza |
Doshi, Peter |
2015 |
386 | 9999 |
p. 1134-1135 2 p. |
artikel |
|
| 22 | Oseltamivir for influenza – Authors' reply |
Monto, Arnold S |
2015 |
386 | 9999 |
p. 1135-1136 2 p. |
artikel |
|
| 23 | Promoting women's health for sustainable development |
Kim, Jim Yong |
2015 |
386 | 9999 |
p. e9-e10 nvt p. |
artikel |
|
| 24 | SDGs will not be achieved without drug policy reform |
Tinasti, Khalid |
2015 |
386 | 9999 |
p. 1132- 1 p. |
artikel |
|
| 25 | Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial |
McInnes, Iain B |
2015 |
386 | 9999 |
p. 1137-1146 10 p. |
artikel |
|
| 26 | Snake bite—the neglected tropical disease |
The Lancet, |
2015 |
386 | 9999 |
p. 1110- 1 p. |
artikel |
|
| 27 | Tax, aid, and health expenditure |
O'Hare, Bernadette |
2015 |
386 | 9999 |
p. 1133- 1 p. |
artikel |
|
| 28 | Tension hydropneumopericardium after routine intubation |
Ghayumi, Mohammad Ali |
2015 |
386 | 9999 |
p. e13- 1 p. |
artikel |
|
| 29 | Transgression and redemption |
Ginn, Stephen |
2015 |
386 | 9999 |
p. 1125- 1 p. |
artikel |
|
| 30 | UN set to change the world with new development goals |
Maurice, John |
2015 |
386 | 9999 |
p. 1121-1124 4 p. |
artikel |
|
| 31 | Valuing the health and contribution of women is central to global development |
Gates, Melinda |
2015 |
386 | 9999 |
p. e11-e12 nvt p. |
artikel |
|
| 32 | Women and Health: the key for sustainable development |
Langer, Ana |
2015 |
386 | 9999 |
p. 1165-1210 46 p. |
artikel |
|
| 33 | Women are the key to sustainable development |
The Lancet, |
2015 |
386 | 9999 |
p. 1110- 1 p. |
artikel |
33 gevonden resultaten